Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis [Phase 2]
Pfizer completed a Phase 2 trial evaluating the efficacy and safety of AN2898 and AN2728 topical ointments for mild-to-moderate atopic derma…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis [Phase 3]
Phase 3 study evaluating safety and efficacy of 2% AN2728 topical ointment in children, adolescents, and adults aged 2 years and older with …
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis [Phase 2]
Pfizer's AN2728 (crisaborole) topical ointment was studied in adolescents with atopic dermatitis in a Phase 2 trial to assess efficacy and s…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema [Phase 2]
Johnson & Johnson Consumer Inc. completed a Phase 2 trial evaluating an over-the-counter cream for dry, itchy skin in adults and children wi…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis [Phase 3]
Phase 3 trial evaluating the safety and efficacy of AN2728 (crisaborole) 2% topical ointment in children, adolescents, and adults aged 2 yea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Animal Allergy in Korean Veterinary Researcher
This clinical trial update describes a study on animal allergy conducted by a Korean veterinary researcher. Conditions include allergic rhin…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot [EARLY_Phase 1]
Early-phase 1 influenza vaccine pilot conducted within the Atopic Dermatitis Research Network has completed; the study status is reported as…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis [Phase 4]
A Phase 4 clinical trial update evaluating the use of pimecrolimus cream 1% to support reconstitution of steroid-damaged skin in adults with…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients [Phase 2]
A Phase 2 study evaluating the safety and efficacy of QGE031 in patients with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis [Phase 1, Phase 2]
Clinical trial update reporting on the efficacy and tolerability of HAT1 in adults with moderate-to-severe atopic dermatitis across Phase 1/…
-
FDA approval · 2017-02-16FDA Approved: CLOBETASOL PROPIONATE — Original Application (Zydus Lifesciences Limited)
FDA approved the original ANDA for clobetasol propionate topical corticosteroid from Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Indigo Naturalis in Treating Atopic Dermatitis Topically [Phase 2]
A completed Phase 2 trial evaluating the safety and efficacy of topical Indigo Naturalis for atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis [Phase 3]
Phase 3 clinical trial evaluating Broncho-Vaxom (OM-85 BV) in children with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic Skin [NA]
A clinical trial evaluating the in-use tolerance of E45 Eczema Repair Emollient in babies and children with very dry or atopic skin has comp…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis: Randomized, Double-blind Controlled Trial [NA]
Randomized, double-blind trial evaluating whether fermented rice flour improves symptoms of atopic dermatitis in children and infants; curre…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis [Phase 1]
A Phase 1 study evaluated the safety and tolerability of XmAb7195 in healthy adults and adults with allergic rhinitis, allergic conjunctivit…
-
FDA label_change · 2017-01-13FDA Approved: CORDRAN — Supplemental Application (Almirall, LLC)
FDA approved a supplemental application for CORDRAN (flurandrenolide) filed by Almirall, LLC, likely affecting labeling.
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema [Phase 2]
Phase 2 study evaluating the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of the topical SB011 formulation in lesi…
-
FDA approval · 2017-01-12FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approves Cosette Pharmaceuticals' original ANDA for Triamcinolone Acetonide topical (generic), clearing a new generic product on the mar…
-
FDA approval · 2017-01-11FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' desoximetasone topical generic under an Original Application (ANDA 208163).
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Immune Response to Varicella Vaccination in Children With Atopic Dermatitis
A completed NIAID-sponsored trial evaluated the immune response to the varicella vaccine in children with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route [Phase 1]
A Phase 1 study evaluating immune responses to immunization with keyhole limpet hemocyanin delivered by scarification and intradermal routes…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis
This clinical trial update describes a study comparing cathelicidin expression in skin and saliva of patients with atopic dermatitis and pso…
-
FDA approval · 2017-01-09FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' desoximetasone as a generic topical corticosteroid under an original ANDA.
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Persistence of Oral Tolerance to Peanut [Phase 2]
Phase 2 trial results evaluating whether oral tolerance to peanut persists were posted in January 2017. The study enrolled participants with…